Bruce Keyt, Chief Scientific Officer at IGM Biosciences, Inc. (IGMS), sold 3,747 shares at $82.50 ($318K) on 2021-07-06, disclosed to the SEC on 2021-07-06.
Open-market sale of $318k IGMS by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.43 | 1,253 | $112K | 35.3% |
| 2 | $82.50 | 1,247 | $103K | 32.4% |
| 3 | $82.50 | 1,247 | $103K | 32.4% |
| Total | $84.82 avg | 3,747 | $318K | 100% |
| Filing → |
| IGMS | SELL | 2024-03-15 | $40K | — | Filing → |
| IGMS | SELL | 2023-12-15 | $44K | — | Filing → |
| IGMS | SELL | 2023-11-29 | $5K | — | Filing → |